Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid.
暂无分享,去创建一个
Yuta Hara | Shunsuke Kataoka | Toshio Matsuda | T. Matsuda | Y. Ago | K. Takuma | Yukio Ago | Kazuhiro Takuma | Yuko Maeda | Yuta Hara | S. Kataoka | Yuko Maeda
[1] D. O’Carroll,et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.
[2] R. Adolphs. The neurobiology of social cognition , 2001, Current Opinion in Neurobiology.
[3] P. Arlotta,et al. Neuronal subtype specification in the cerebral cortex , 2007, Nature Reviews Neuroscience.
[4] M. Rutter,et al. Autism , 1978, Springer US.
[5] D. Molfese,et al. Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.
[6] R. Przewłocki,et al. Environmental Enrichment Reverses Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Issues for a Therapeutic Approach in Autism , 2006, Neuropsychopharmacology.
[7] E. Arenas,et al. Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway , 2008, BMC Cell Biology.
[8] B. Scatton,et al. Inhibitory influence of GABA on central serotonergic transmission. Involvement of the habenulo-raphe´pathways in the GABAergic inhibition of ascending cerebral serotonergic neurons , 1985, Brain Research.
[9] T. Eckschlager,et al. Valproic acid in the complex therapy of malignant tumors. , 2010, Current drug targets.
[10] C. McDougle,et al. Structural and functional magnetic resonance imaging of autism spectrum disorders , 2011, Brain Research.
[11] W. Freed,et al. Cocaine causes deficits in radial migration and alters the distribution of glutamate and GABA neurons in the developing rat cerebral cortex , 2011, Synapse.
[12] Jindrich Cinatl,et al. Anti‐tumor mechanisms of valproate: A novel role for an old drug , 2002, Medicinal research reviews.
[13] C. Lord,et al. Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.
[14] Eric Courchesne,et al. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism , 1997, Current Opinion in Neurobiology.
[15] M. Carducci,et al. Multiple Molecular pathways explain the anti‐proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo , 2007, The Prostate.
[16] D. Gilliam,et al. Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[17] Armin Schumacher,et al. The Nuclear Kinase Mitogen- and Stress-Activated Protein Kinase 1 Regulates Hippocampal Chromatin Remodeling in Memory Formation , 2007, The Journal of Neuroscience.
[18] D. Geschwind,et al. Autism spectrum disorders: developmental disconnection syndromes , 2007, Current Opinion in Neurobiology.
[19] H. Damasio,et al. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. , 2000, Brain : a journal of neurology.
[20] J. Hersh,et al. A male with fetal valproate syndrome and autism , 1997, Developmental medicine and child neurology.
[21] B. Kerr,et al. Fetal valproate syndrome and autism , 2001 .
[22] Christoph Schmitz,et al. Neurons in the fusiform gyrus are fewer and smaller in autism. , 2008, Brain : a journal of neurology.
[23] P. Turnpenny,et al. A clinical study of 57 children with fetal anticonvulsant syndromes , 2000 .
[24] G. Bartzokis,et al. Biological underpinnings of treatment resistance in schizophrenia: an hypothesis. , 2003, Psychopharmacology bulletin.
[25] M. Eadie. Antiepileptic drugs as human teratogens , 2008 .
[26] S. Purgato,et al. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. , 2005, Oncology reports.
[27] H. Nau,et al. S-2-PENTYL-4-PENTYNOIC HYDROXAMIC ACID AND ITS METABOLITE S-2-PENTYL-4-PENTYNOIC ACID IN THE NMRI-EXENCEPHALY-MOUSE MODEL: PHARMACOKINETIC PROFILES, TERATOGENIC EFFECTS, AND HISTONE DEACETYLASE INHIBITION ABILITIES OF FURTHER VALPROIC ACID HYDROXAMATES AND AMIDES , 2006, Drug Metabolism and Disposition.
[28] S. Moy,et al. Mouse models of autism spectrum disorders: The challenge for behavioral genetics , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.
[29] L. Wing,et al. Early childhood autism : clinical, educational and social aspects , 1966 .
[30] M. Guenther,et al. Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.
[31] K. Reuhl,et al. A New Neurobehavioral Model of Autism in Mice: Pre- and Postnatal Exposure to Sodium Valproate , 2006, Journal of autism and developmental disorders.
[32] S. Aizawa,et al. Absence of Cajal-Retzius cells and subplate neurons associated with defects of tangential cell migration from ganglionic eminence in Emx1/2 double mutant cerebral cortex. , 2002, Development.
[33] T. Henry. The history of valproate in clinical neuroscience. , 2003, Psychopharmacology bulletin.
[34] M. Coleman. A Report on the Autistic Syndromes , 1978 .
[35] L. Thompson,et al. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.
[36] D. deCatanzaro,et al. Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid , 2010, Neuroscience.
[37] H. Mizoguchi,et al. 17β-estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats , 2007, Neuroscience.
[38] J. Greenwood,et al. Valproic acid induces caspase 3-mediated apoptosis in microglial cells , 2006, Neuroscience.
[39] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[40] P. Rodier,et al. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. , 2000, Neurotoxicology and teratology.
[41] Wolfgang Schmid,et al. Disruption of CREB function in brain leads to neurodegeneration , 2002, Nature Genetics.
[42] Angelica Ronald,et al. Autism spectrum disorders and autistic traits: A decade of new twin studies , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[43] L. Winn,et al. Epigenetic modifications in valproic acid-induced teratogenesis. , 2010, Toxicology and applied pharmacology.
[44] O. Marín,et al. A long, remarkable journey: Tangential migration in the telencephalon , 2001, Nature Reviews Neuroscience.
[45] J. Gustafsson,et al. Estrogen receptor (ER)β knockout mice reveal a role for ERβ in migration of cortical neurons in the developing brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] C. Salafia,et al. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma. , 2006, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[47] H. Markram,et al. Abnormal Fear Conditioning and Amygdala Processing in an Animal Model of Autism , 2008, Neuropsychopharmacology.
[48] K. Mikoshiba,et al. Neuronal Birthdate-Specific Gene Transfer with Adenoviral Vectors , 2004, The Journal of Neuroscience.
[49] Kwang Ho Ko,et al. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. , 2011, Toxicology letters.
[50] T. Bourgeron,et al. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues , 2006, Trends in Neurosciences.
[51] A. Ornoy. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? , 2009, Reproductive toxicology.
[52] H. Manji,et al. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers , 2004, Molecular Psychiatry.
[53] M. Beale,et al. Psychotropic drug-induced weight gain alleviated with orlistat: a case series. , 2003, Psychopharmacology bulletin.
[54] P. Kwan,et al. The mechanisms of action of commonly used antiepileptic drugs. , 2001, Pharmacology & therapeutics.
[55] Ryszard Przewłocki,et al. Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism , 2005, Neuropsychopharmacology.